Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Outcomes-Based Pricing as a Tool to Ensure Access to Novel but Expensive Biopharmaceuticals.

× No keyword cloud information.

5 in total

Review 1. Why Are Diabetes Medications So Expensive and What Can Be Done to Control Their Cost?

Authors: Laura N McEwen; Sarah Stark Casagrande; Shihchen Kuo; William H Herman
Journal: Curr Diab Rep Date: 2017-09 Impact factor: 4.810

Review 2. When Less May Be Enough: Dose Selection Strategies for Immune Checkpoint Inhibitors Focusing on AntiPD-(L)1 Agents.

Authors: Daniel V Araujo; Bruno Uchoa; Juan José Soto-Castillo; Larissa L Furlan; Marc Oliva
Journal: Target Oncol Date: 2022-06-10 Impact factor: 4.864

Review 3. 100 years of Insulin: Why is Insulin So Expensive and What Can be Done to Control Its Cost?

Authors: William H Herman; Shihchen Kuo
Journal: Endocrinol Metab Clin North Am Date: 2021-10-14 Impact factor: 4.748

4. Value-based Pricing for Rifaximin Increases Access of Patients With Irritable Bowel Syndrome With Diarrhea to Therapy.

Authors: Eric D Shah; Sameer D Saini; William D Chey
Journal: Clin Gastroenterol Hepatol Date: 2019-03-01 Impact factor: 11.382

5. The economics of alternative payment models for pharmaceuticals.

Authors: Jakub P Hlávka; Jeffrey C Yu; Dana P Goldman; Darius N Lakdawalla
Journal: Eur J Health Econ Date: 2021-03-16

5 in total